Subscribe
A worldwide window to Cambridge business, innovation and technology
Sanger Institute and collaborators discover new drug target for eye cancer

Sanger Institute and collaborators discover new drug target for eye cancer

Cambridge-driven research has identified a novel target with therapeutic potential for metastatic eye melanoma — an aggressive eye cancer — with implications for a range of other cancers.
$40m 'Superman' backed fund partners with Healx to fight paralysis

$40m 'Superman' backed fund partners with Healx to fight paralysis

A $40 million London-based fund backed by the Christopher & Dana Reeve Foundation, among others, today unveils its first major investment – and Cambridge AI drug discovery company Healx is the beneficiary.
Wellcome Sanger Institute pursues fresh frontiers to build on rich genomics legacy

Wellcome Sanger Institute pursues fresh frontiers to build on rich genomics legacy

The Wellcome Sanger Institute in Cambridge is investigating potential new areas of genomics techniques – still restless for progress despite having mapped the Human Genome exactly 25 years ago today.
AnthroTek closes £950k seed round and eyes £12m valuation

AnthroTek closes £950k seed round and eyes £12m valuation

Exciting Cambridge startup AnthroTek has clinched £950,000 in seed funding at a pre-money valuation of £10.5 million. The company projects this valuation will rise to around £12m on completion of an additional £550k tranche expected within the next 12 months.
San Jose Sharks devour AI from Cambridge Consultants

San Jose Sharks devour AI from Cambridge Consultants

The NHL’s San Jose Sharks have collaborated with Cambridge Consultants, the DeepTech powerhouse of Capgemini, and leading sports advisory firm Sportsology to explore new approaches in ice hockey coaching through the adoption of AI in sport.
Academia
Sharewatch
Manufacturing
Sanger Institute and collaborators discover new drug target for eye cancer
04 Jul 2025 - 12:00
Impulse programme entrepreneurs boost AI and robotics innovation
03 Jul 2025 - 12:00
Cambridge scientists' findings could counteract genetic damage of some chemotherapy treatments
01 Jul 2025 - 12:00

Business awards

Entries now being accepted

Business directory

Browse our listings of Cambridge companies

The killer 50

The 50 hottest disruptive technology companies

News

Sanger Institute and collaborators discover new drug target for eye cancer

Sanger Institute and collaborators discover new drug target for eye cancer

Cambridge-driven research has identified a novel target with therapeutic potential for metastatic eye melanoma — an aggressive eye cancer — with implications for a range of other cancers.
Less than 0.02 per cent of therapeutic concepts hit the market, symposium guests learn

Less than 0.02 per cent of therapeutic concepts hit the market, symposium guests learn

Cutting-edge research and its translation into novel therapeutics was championed as the Milner Therapeutics Institute in Cambridge hosted its annual Symposium – a hybrid event welcoming around 500 in-person delegates and 250+ online attendees.
Codasip invites potential acquirers to show themselves

Codasip invites potential acquirers to show themselves

German technology company Codasip, which has a design centre in Cambridge, is selling the business despite being cash-rich and under no obvious pressure. It appears the move has been triggered by talk of an acquisition of the Munich business.
Impulse programme entrepreneurs boost AI and robotics innovation

Impulse programme entrepreneurs boost AI and robotics innovation

Entrepreneurs in Cambridge University’s Impulse programme are working on top-tier advancements to take artificial intelligence to an unprecedented level.
More news

Tech trail

University of Cambridge spin-out eyes Japan’s manufacturing giants

University of Cambridge spin-out eyes Japan’s manufacturing giants

Accelerated Materials - founded in 2020 by Dr Nicholas Jose with Cambridge University colleagues Professor Alexei Lapkin and Dr Mikhail Kovalev – has since developed a platform to help manufacturers overcome a perennial challenge: how to scale laboratory breakthroughs into industrial processes that are both commercially viable and cost-effective. And it’s making good progress in expanding its business in Japan.
$40m 'Superman' backed fund partners with Healx to fight paralysis

$40m 'Superman' backed fund partners with Healx to fight paralysis

A $40 million London-based fund backed by the Christopher & Dana Reeve Foundation, among others, today unveils its first major investment – and Cambridge AI drug discovery company Healx is the beneficiary.
Serve First raises £4.6m to expand AI into Europe and US

Serve First raises £4.6m to expand AI into Europe and US

Serve First, an AI-driven customer experience and feedback management platform with its HQ in Milton Keynes, has raised £4.6 million from Pembroke VCT and the Midlands Engine Investment Fund II, through its appointed fund manager Mercia Ventures, alongside Tiny VCT, Techstars and angel investors.
Cambridge battery innovator making inroads in Asia

Cambridge battery innovator making inroads in Asia

A Cambridge company is making waves in Asia’s battery sector with a novel material that delivers faster charging and improved safety for industrial vehicles.
More Tech trail

Trade floor

Codasip invites potential acquirers to show themselves

Codasip invites potential acquirers to show themselves

German technology company Codasip, which has a design centre in Cambridge, is selling the business despite being cash-rich and under no obvious pressure. It appears the move has been triggered by talk of an acquisition of the Munich business.
More accurate metabolism models at heart of Cambridge-Estonia research

More accurate metabolism models at heart of Cambridge-Estonia research

Optibrium, a Cambridge-based developer of software and AI solutions for molecular design, has partnered with TalTech (Tallinn University of Technology) in Estonia to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme.
Nu Quantum CEO wants more collaboration to fast-track quantum computing

Nu Quantum CEO wants more collaboration to fast-track quantum computing

Transatlantic startup Nu Quantum, steered from Cambridge UK, has morphed from contributor to conductor in a fresh initiative designed to accelerate the growth of quantum computing.
Malaysia in the LOOP for Levidian technology

Malaysia in the LOOP for Levidian technology

Cambridge ClimateTech doyen Levidian Nanosystems has further clinched significant global glory as it continues to decarbonise some of the world's most carbon-intensive industries. Its patented LOOP technology has now been chosen by Gas Malaysia Berhad.
PEM’s corporate finance team advises on sale of Greenhouses Direct

PEM’s corporate finance team advises on sale of Greenhouses Direct

Cambridge-based PEM has advised the shareholders of Greenhouses Direct Limited on the sale of the business to Mirabel Group Limited and Kantik Limited for an undisclosed sum.
More Trade floor